OBJECTIVE: The objective of the study was to ascertain the association between fetal growth (small- [SGA], appropriate- [AGA], and large-for-gestational-age [LGA]) and early, late, and postneonatal mortality. STUDY DESIGN: Birth certificate data for nonanomalous singletons, delivered from 1996 to 2007, were obtained for Milwaukee residents. Multivariate logistic regression analyses, adjusted for 19 covariates, determined the association between fetal growth and mortality. RESULTS: Among the 123,383 live births, SGA was 57% higher than LGA (11% vs 7%). The infant mortality rate for SGA was 11.0, AGA, 5.3, and LGA, 2.7/1000 live births. SGA was a significant risk factor for early (adjusted odds ratio, 2.66) and late (2.06) but not postneonatal mortality. The adjusted risk of mortality for LGA was not significantly different from AGA. Over 12 years, 3 types of mortality for aberrant fetal growth did not change significantly. CONCLUSION: In the city of Milwaukee, aberrant fetal growth was variably associated with early, late, and postneonatal mortality.
OBJECTIVE: The objective of the study was to ascertain the association between fetal growth (small- [SGA], appropriate- [AGA], and large-for-gestational-age [LGA]) and early, late, and postneonatal mortality. STUDY DESIGN: Birth certificate data for nonanomalous singletons, delivered from 1996 to 2007, were obtained for Milwaukee residents. Multivariate logistic regression analyses, adjusted for 19 covariates, determined the association between fetal growth and mortality. RESULTS: Among the 123,383 live births, SGA was 57% higher than LGA (11% vs 7%). The infant mortality rate for SGA was 11.0, AGA, 5.3, and LGA, 2.7/1000 live births. SGA was a significant risk factor for early (adjusted odds ratio, 2.66) and late (2.06) but not postneonatal mortality. The adjusted risk of mortality for LGA was not significantly different from AGA. Over 12 years, 3 types of mortality for aberrant fetal growth did not change significantly. CONCLUSION: In the city of Milwaukee, aberrant fetal growth was variably associated with early, late, and postneonatal mortality.
Authors: D Iafusco; A Galderisi; F Lombardo; A Scaramuzza; E Tartaglia; A Cocca; R Giugliano; B Giugliano; T Sena; A Napoli; P Mastrantonio; F Stoppoloni; F Prisco Journal: Diabetologia Date: 2011-03-13 Impact factor: 10.122
Authors: Melissa G Rosenstein; Yvonne W Cheng; Jonathan M Snowden; James M Nicholson; Amy E Doss; Aaron B Caughey Journal: Am J Obstet Gynecol Date: 2012-04 Impact factor: 8.661
Authors: Suneet P Chauhan; Madeline Murguia Rice; William A Grobman; Jennifer Bailit; Uma M Reddy; Ronald J Wapner; Michael W Varner; John M Thorp; Kenneth J Leveno; Steve N Caritis; Mona Prasad; Alan T N Tita; George Saade; Yoram Sorokin; Dwight J Rouse; Jorge E Tolosa Journal: Obstet Gynecol Date: 2017-09 Impact factor: 7.661
Authors: María Emilia Solano; Mirka Katharina Kowal; Greta Eugenia O'Rourke; Andrea Kristina Horst; Kathrin Modest; Torsten Plösch; Roja Barikbin; Chressen Catharina Remus; Robert G Berger; Caitlin Jago; Hoang Ho; Gabriele Sass; Victoria J Parker; John P Lydon; Francesco J DeMayo; Kurt Hecher; Khalil Karimi; Petra Clara Arck Journal: J Clin Invest Date: 2015-03-16 Impact factor: 14.808
Authors: Melissa G Rosenstein; Yvonne W Cheng; Jonathan M Snowden; James M Nicholson; Aaron B Caughey Journal: Obstet Gynecol Date: 2012-07 Impact factor: 7.661
Authors: Ibrahim A Hammad; Suneet P Chauhan; Malgorzata Mlynarczyk; Nader Rabie; Chris Goodie; Eugene Chang; Everett F Magann; Alfred Z Abuhamad Journal: AJP Rep Date: 2015-11-16
Authors: Hyun Sun Ko; Jeong Ha Wie; Sae Kyung Choi; In Yang Park; Yong-Gyu Park; Jong Chul Shin Journal: PLoS One Date: 2018-12-14 Impact factor: 3.240